Loading…

Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview

Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology and applied biochemistry 2020-11, Vol.67 (6), p.920-928
Main Authors: Chung, Ill‐Min, Rajakumar, Govindasamy, Subramanian, Umadevi, Venkidasamy, Baskar, Khanna, Venkatesan Gopiesh, Thiruvengadam, Muthu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73
cites cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73
container_end_page 928
container_issue 6
container_start_page 920
container_title Biotechnology and applied biochemistry
container_volume 67
creator Chung, Ill‐Min
Rajakumar, Govindasamy
Subramanian, Umadevi
Venkidasamy, Baskar
Khanna, Venkatesan Gopiesh
Thiruvengadam, Muthu
description Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review. Treatment strategies of type 2 diabetes.
doi_str_mv 10.1002/bab.1853
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2315526035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2477153112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</originalsourceid><addsrcrecordid>eNp1kV1rFDEUhoModlsFf4EEvPFmar5mk3i3LVoLhd7U63CSOWNTZiZrktmy_97ZtioUenXg5eHh5byEfODslDMmvnjwp9y08hVZcaVZY7RSr8mKGdM2quXyiByXcscYM9qIt-RIci3X3KoVyZdTib9ua6FpovUWaZhzxqnSUqHOhcLUUeh2MAUcD3HqaRfBY8VCRxyGeIDqfotUPLA1UdhhrjSkcTvEADWmqXylm4mmJd9FvH9H3vQwFHz_dE_Iz-_fbs5_NFfXF5fnm6smSGVl01nU0ggVwPp1p8F7NAqMtaEHaSxo3QN03Ji1Ytay3vRGdhKNt5x7EbQ8IZ8fvducfs9YqhtjCUtnmDDNxQnJ21asmWwX9NMz9C7NeVraOaG05q3kXPwXhpxKydi7bY4j5L3jzB12cMsO7rDDgn58Es5-xO4f-PfxC9A8AvdxwP2LIne2OXsQ_gGlCZFz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2477153112</pqid></control><display><type>article</type><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</creator><creatorcontrib>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</creatorcontrib><description>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review. Treatment strategies of type 2 diabetes.</description><identifier>ISSN: 0885-4513</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1002/bab.1853</identifier><identifier>PMID: 31736194</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aging ; antiglycemic agents ; Beta cells ; completions ; Complications ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; diabetes mellitus type 2 ; Insulin ; Insulin resistance ; Metabolic disorders ; Modernization ; Pancreas ; Pathophysiology ; Physical activity ; treatment strategies</subject><ispartof>Biotechnology and applied biochemistry, 2020-11, Vol.67 (6), p.920-928</ispartof><rights>2019 International Union of Biochemistry and Molecular Biology, Inc.</rights><rights>2020 International Union of Biochemistry and Molecular Biology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</citedby><cites>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</cites><orcidid>0000-0003-0986-5484</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31736194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chung, Ill‐Min</creatorcontrib><creatorcontrib>Rajakumar, Govindasamy</creatorcontrib><creatorcontrib>Subramanian, Umadevi</creatorcontrib><creatorcontrib>Venkidasamy, Baskar</creatorcontrib><creatorcontrib>Khanna, Venkatesan Gopiesh</creatorcontrib><creatorcontrib>Thiruvengadam, Muthu</creatorcontrib><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnol Appl Biochem</addtitle><description>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review. Treatment strategies of type 2 diabetes.</description><subject>Aging</subject><subject>antiglycemic agents</subject><subject>Beta cells</subject><subject>completions</subject><subject>Complications</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>diabetes mellitus type 2</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Metabolic disorders</subject><subject>Modernization</subject><subject>Pancreas</subject><subject>Pathophysiology</subject><subject>Physical activity</subject><subject>treatment strategies</subject><issn>0885-4513</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kV1rFDEUhoModlsFf4EEvPFmar5mk3i3LVoLhd7U63CSOWNTZiZrktmy_97ZtioUenXg5eHh5byEfODslDMmvnjwp9y08hVZcaVZY7RSr8mKGdM2quXyiByXcscYM9qIt-RIci3X3KoVyZdTib9ua6FpovUWaZhzxqnSUqHOhcLUUeh2MAUcD3HqaRfBY8VCRxyGeIDqfotUPLA1UdhhrjSkcTvEADWmqXylm4mmJd9FvH9H3vQwFHz_dE_Iz-_fbs5_NFfXF5fnm6smSGVl01nU0ggVwPp1p8F7NAqMtaEHaSxo3QN03Ji1Ytay3vRGdhKNt5x7EbQ8IZ8fvducfs9YqhtjCUtnmDDNxQnJ21asmWwX9NMz9C7NeVraOaG05q3kXPwXhpxKydi7bY4j5L3jzB12cMsO7rDDgn58Es5-xO4f-PfxC9A8AvdxwP2LIne2OXsQ_gGlCZFz</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Chung, Ill‐Min</creator><creator>Rajakumar, Govindasamy</creator><creator>Subramanian, Umadevi</creator><creator>Venkidasamy, Baskar</creator><creator>Khanna, Venkatesan Gopiesh</creator><creator>Thiruvengadam, Muthu</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>L7M</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0986-5484</orcidid></search><sort><creationdate>202011</creationdate><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><author>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aging</topic><topic>antiglycemic agents</topic><topic>Beta cells</topic><topic>completions</topic><topic>Complications</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>diabetes mellitus type 2</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Metabolic disorders</topic><topic>Modernization</topic><topic>Pancreas</topic><topic>Pathophysiology</topic><topic>Physical activity</topic><topic>treatment strategies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chung, Ill‐Min</creatorcontrib><creatorcontrib>Rajakumar, Govindasamy</creatorcontrib><creatorcontrib>Subramanian, Umadevi</creatorcontrib><creatorcontrib>Venkidasamy, Baskar</creatorcontrib><creatorcontrib>Khanna, Venkatesan Gopiesh</creatorcontrib><creatorcontrib>Thiruvengadam, Muthu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chung, Ill‐Min</au><au>Rajakumar, Govindasamy</au><au>Subramanian, Umadevi</au><au>Venkidasamy, Baskar</au><au>Khanna, Venkatesan Gopiesh</au><au>Thiruvengadam, Muthu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnol Appl Biochem</addtitle><date>2020-11</date><risdate>2020</risdate><volume>67</volume><issue>6</issue><spage>920</spage><epage>928</epage><pages>920-928</pages><issn>0885-4513</issn><eissn>1470-8744</eissn><abstract>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review. Treatment strategies of type 2 diabetes.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31736194</pmid><doi>10.1002/bab.1853</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0986-5484</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0885-4513
ispartof Biotechnology and applied biochemistry, 2020-11, Vol.67 (6), p.920-928
issn 0885-4513
1470-8744
language eng
recordid cdi_proquest_miscellaneous_2315526035
source Wiley-Blackwell Read & Publish Collection
subjects Aging
antiglycemic agents
Beta cells
completions
Complications
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
diabetes mellitus type 2
Insulin
Insulin resistance
Metabolic disorders
Modernization
Pancreas
Pathophysiology
Physical activity
treatment strategies
title Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T11%3A54%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insights%20on%20the%20current%20status%20and%20advancement%20of%20diabetes%20mellitus%20type%202%20and%20to%20avert%20complications:%20An%20overview&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Chung,%20Ill%E2%80%90Min&rft.date=2020-11&rft.volume=67&rft.issue=6&rft.spage=920&rft.epage=928&rft.pages=920-928&rft.issn=0885-4513&rft.eissn=1470-8744&rft_id=info:doi/10.1002/bab.1853&rft_dat=%3Cproquest_cross%3E2477153112%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2477153112&rft_id=info:pmid/31736194&rfr_iscdi=true